{
  "id": "5ca0848aecadf2e73f000044",
  "type": "yesno",
  "question": "Are there any anti-amyloid antibody approved as drug for Alzheimer's disease treatment?",
  "ideal_answer": "No new drugs have been approved during the past 15 years; and the available medications are not cost-effective.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29607687",
    "http://www.ncbi.nlm.nih.gov/pubmed/26697860"
  ],
  "snippets": [
    {
      "text": "Treatment with memantine, a noncompetitive NMDA receptor antagonist which is an approved drug for treatment of Alzheimer's disease, rescued protein phosphatase-2A activity by decreasing its demethylation at Leu309 selectively and attenuated Alzheimer's disease-like pathology and cognitive impairment in adeno-associated virus vector-1-I1PP2A rats. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26697860",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "anti-Amyloid agents (13.30%)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29607687",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "no new drugs have been approved during the past 15\u00a0years; and the available medications are not cost-effective. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29607687",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}